Cargando…
Impacts on product quality attributes of monoclonal antibodies produced in CHO cell bioreactor cultures during intentional mycoplasma contamination events
A mycoplasma contamination event in a biomanufacturing facility can result in costly cleanups and potential drug shortages. Mycoplasma may survive in mammalian cell cultures with only subtle changes to the culture and penetrate the standard 0.2‐µm filters used in the clarification of harvested cell...
Autores principales: | Fratz‐Berilla, Erica J., Angart, Phillip, Graham, Ryan J., Powers, David N., Mohammad, Adil, Kohnhorst, Casey, Faison, Talia, Velugula‐Yellela, Sai Rashmika, Trunfio, Nicholas, Agarabi, Cyrus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496122/ https://www.ncbi.nlm.nih.gov/pubmed/32436993 http://dx.doi.org/10.1002/bit.27436 |
Ejemplares similares
-
Impacts of intentional mycoplasma contamination on CHO cell bioreactor cultures
por: Fratz‐Berilla, Erica J., et al.
Publicado: (2019) -
Use of High-Throughput Automated Microbioreactor System for Production of Model IgG1 in CHO Cells
por: Velugula-Yellela, Sai Rashmika, et al.
Publicado: (2018) -
Real‐time quantification and supplementation of bioreactor amino acids to prolong culture time and maintain antibody product quality
por: Powers, David N., et al.
Publicado: (2019) -
Impact of media and antifoam selection on monoclonal antibody production and quality using a high throughput micro‐bioreactor system
por: Velugula‐Yellela, Sai Rashmika, et al.
Publicado: (2017) -
Multivariate data analysis of growth medium trends affecting antibody glycosylation
por: Powers, David N., et al.
Publicado: (2019)